DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Efficacy of Exercise for Sexual Side Effects of Antidepressants

Information source: University of Texas at Austin
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Sexual Dysfunction

Intervention: Exercise (Behavioral)

Phase: N/A

Status: Completed

Sponsored by: University of Texas at Austin

Official(s) and/or principal investigator(s):
Tierney K Ahrold Lorenz, M.A., Principal Investigator, Affiliation: University of Texas at Austin

Summary

The major aim of the this study is to replicate findings of previous research that examined the effects of acute exercise on sexual arousal in women in a novel population, namely, women taking antidepressants of the selective serotonin reuptake inhibitors (SSRI) or selective serotonin and norepinephrine reuptake inhibitors (SNRI) class. In previous studies it has been found that acute, moderate-intensity exercise facilitated physiological sexual arousal responses in healthy, sexually functional women. However, it is known that antidepressants may induce sexual dysfunction, and thus in the present study, the investigators are examining whether acute exercise may facilitate sexual responses in women with taking antidepressants, including women with antidepressant-related sexual dysfunction.

Clinical Details

Official title: Effects of Acute Exercise on Sexual Arousal in Women Taking a Selective Serotonin Reuptake Inhibitor (SSRI) or Selective Serotonin/Norepinephrine Reuptake Inhibitor

Study design: Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Primary outcome: Sexual arousal

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Female.

Criteria:

Inclusion Criteria:

- female

- age 18 or older

- currently receiving a consistent dosage of escitalopram, citalopram, sertraline,

desvenlafaxine, venlafaxine, or duloxetine

- currently sexually active

- willing and able to exercise

- experiencing regular menstrual cycles

- not currently pregnant and not intending to become pregnant during trial

Exclusion Criteria:

- currently taking more than one psychoactive medication

- factors indicating risk of cardiovascular activity, including acute or chronic

cardiovascular illness, including clinically significant hypertension (defined as self-reported hypertension or "blood pressure greater than 140/90" or receiving medications designed to treat hypertension); recent chest pain; frequent or recurrent faint or dizzy spells; severe or untreated exercise-related asthma; or musculoskeletal illness or injury that would be expected to worsen with physical exercise. Additionally, women will be excluded if they are found to have any of the following as measured during the fitness assessment of the first session: a BMI over 40, waist circumference over 40 inches, waist-to-hip ratio of greater than 0. 9, systolic blood pressure greater than 150 or diastolic pressure over 95, or resting heart rate over 90.

- factors associated with significant genital nerve damage, including: previous major

pelvic surgery that may have caused nerve damage, including hysterectomy, vulvectomy, circumcision, colostomy, cystostomy, or serious bladder, rectal, or abdominal surgery; or neurological impairment due to diabetes, stroke, pelvic nerve damage secondary to trauma, cancer treatments, myasthenia gravis, multiple sclerosis or spinal cord damage.

- factors associated with non-normative endocrine function, including: perimenopausal

or menopausal status, or >1 missed menstrual period in the previous 6 months; or currently pregnant, breastfeeding, or having breastfed within the past 3 months; or reporting clinically significant untreated renal or endocrine disease

- untreated serious mental health conditions

- sexual aversion or distress due to history of unwanted sexual contact

Locations and Contacts

University of Texas at Austin, Austin, Texas 78712, United States
Additional Information

Laboratory webpage

Starting date: June 2009
Last updated: February 25, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017